miltefosine has been researched along with triazoles in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 9 (69.23) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Farmen, S; Kaul, DR; Khaled, YA; Lowe, L; Visvesvara, GS; Yanik, GA | 1 |
Bellemore, MC; Ellis, DH; Kesson, AM; O'Mara, TJ; Sorrell, TC | 1 |
Click, J; Gee, SN; Hsu, MY; Rothschild, B; Saavedra, A; Sheth, V | 1 |
Benaim, B; Garcia, CR | 1 |
Bilbao, J; Duplisea, K; Guiot, MC; Kolyvas, G; Qvarnstrom, Y; Umar, I; Visvesvara, GS; Webster, D | 1 |
Biswas, C; Chen, SC; Djordjevic, JT; Jolliffe, KA; Sorrell, TC; Zuo, X | 1 |
Jiang, J; Mathur, R; Pandharkar, T; Schmittgen, TD; Shaha, C; Werbovetz, KA; Zhu, X | 1 |
Bosschaerts, T; Boulet, G; Cos, P; Fortin, A; Maes, L; Paulussen, C | 1 |
Botero, A; Keatley, S; Peacock, C; Thompson, RC | 1 |
Antinarelli, LMR; Carmo, AML; Coimbra, ES; da Silva, AD; Gameiro, J; Stroppa, PHF | 1 |
Braga, SS | 1 |
Almeida, ADC; Coimbra, ES; da Silva, AD; Glanzmann, N; Meinel, RS; Stroppa, PHF | 1 |
Abastabar, M; Aghili, SR; Akhtari, J; Al Hatmi, AMS; Al-Harrasi, A; Badali, H; Haghani, I; Hajheydari, Z; Hedayati, MT; Javidnia, J; Kermani, F; Khojasteh, S; Moazeni, M; Shokohi, T; Yahyazadeh, Z | 1 |
2 review(s) available for miltefosine and triazoles
Article | Year |
---|---|
Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.
Topics: Amiodarone; Antiprotozoal Agents; Calcium; Chagas Disease; Homeostasis; Humans; Leishmania; Leishmaniasis; Phosphorylcholine; Triazoles; Trypanosoma brucei brucei; Trypanosoma cruzi | 2011 |
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
11 other study(ies) available for miltefosine and triazoles
Article | Year |
---|---|
Acanthamoeba infection in a patient with chronic graft-versus-host disease occurring during treatment with voriconazole.
Topics: Acanthamoeba; Amebiasis; Animals; Antifungal Agents; Antiprotozoal Agents; Drug Therapy, Combination; Encephalitis; Fatal Outcome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lung; Male; Middle Aged; Phosphorylcholine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Skin; Triazoles; Voriconazole | 2008 |
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.
Topics: Antifungal Agents; Child; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Mycoses; Naphthalenes; Osteomyelitis; Phosphorylcholine; Pyrimidines; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries | 2009 |
Tender ulceronecrotic nodules in a patient with leukemia. Cutaneous acanthamebiasis.
Topics: Acanthamoeba; Amebiasis; Antiprotozoal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Necrosis; Pentamidine; Phosphorylcholine; Pyrimidines; Skin Diseases, Parasitic; Skin Ulcer; Sulfadoxine; Triazoles; Voriconazole | 2011 |
Treatment of granulomatous amoebic encephalitis with voriconazole and miltefosine in an immunocompetent soldier.
Topics: Acanthamoeba; Adult; Amebiasis; Animals; Encephalitis; Granuloma; Humans; Immunocompetence; Male; Military Personnel; Phosphorylcholine; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.
Topics: Antifungal Agents; Drug Synergism; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Phosphorylcholine; Pyrimidines; Triazoles; Voriconazole | 2013 |
Studies on the antileishmanial mechanism of action of the arylimidamide DB766: azole interactions and role of CYP5122A1.
Topics: Amidines; Animals; Antiprotozoal Agents; Axenic Culture; Blotting, Western; Cricetinae; Drug Combinations; Drug Resistance; Drug Synergism; Furans; Gene Expression Regulation; Ketoconazole; Leishmania donovani; Life Cycle Stages; Mice; Phosphorylcholine; Protozoan Proteins; Sterol 14-Demethylase; Triazoles | 2014 |
Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Phosphorylcholine; Pyrimidines; Triazoles; Voriconazole | 2015 |
In vitro drug susceptibility of two strains of the wildlife trypanosome, Trypanosoma copemani: A comparison with Trypanosoma cruzi.
Topics: Animals; Animals, Wild; Australia; Cell Line; Drug Discovery; High-Throughput Screening Assays; Inhibitory Concentration 50; Melarsoprol; Nitroimidazoles; Phosphorylcholine; Potoroidae; Pyrimidines; Triazoles; Trypanocidal Agents; Trypanosoma; Trypanosoma cruzi | 2017 |
Effect of 1,2,3-triazole salts, non-classical bioisosteres of miltefosine, on Leishmania amazonensis.
Topics: Animals; Antiprotozoal Agents; Apoptosis; Cell Line; Erythrocytes; Humans; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages; Mice; Phosphorylcholine; Reactive Oxygen Species; Triazoles | 2017 |
Novel functionalized 1,2,3-triazole derivatives exhibit antileishmanial activity, increase in total and mitochondrial-ROS and depolarization of mitochondrial membrane potential of Leishmania amazonensis.
Topics: Animals; Antiprotozoal Agents; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mitochondria; Phosphorylcholine; Reactive Oxygen Species; Triazoles | 2020 |
Antifungal activity of miltefosine against both azole-susceptible and -resistant Aspergillus strains.
Topics: Antifungal Agents; Aspergillus; Azoles; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2023 |